Skip Navigation U.S. Department of Health and Human Services www.hhs.gov/
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov/
2008 National Healthcare Quality & Disparities Reports

Table 5_2_2.1
Adult patients with HIV and CD4 count <200 who received Pneumocystis pneumonia (PCP) prophylaxis,a United States, 2003 and 2005
Population group 2005 2003
Sample size Percent SE Sample size Percent SE
Total 3,080 90.6 0.5 3,094 83.9 0.7
Age 18–44 1,853 90.8 0.7 1,907 84.2 0.8
45 and over 1,227 90.2 0.8 1,185 83.5 1.1
Race Non-Hispanic, White 788 91.1 1.0 828 83.5 1.3
Non-Hispanic, Black 1,558 90.6 0.7       1,558 83.1 1.0
Hispanic 667 90.3 1.1 655 86.4 1.3
Other 43 90.7 4.5 41 90.2 4.7
Gender Male 2,292 91.9 0.6 2,356 84.7 0.7
Female 768 86.5 1.2 738 81.4 1.4
Health insurance Private 286 90.6 1.7 256 81.6 2.4
Medicaid/dual eligible 1,183 90.0 0.9 1,330 86.6 0.9
Medicare 493 93.3 1.1 405 84.9 1.8
Other/uninsured 566 93.3 1.1 543 84.5 1.6

a For HIV patients having at least two CD4 tests < 200 during the year.

Key: PCP: Pneumocystis pneumonia; SE: standard error.

Source: Agency for Healthcare Research and Quality, Center for Delivery, Organization, and Markets, HIV Research Network.

 

AHRQAdvancing Excellence in Health Care